CytRx (CYTR) Tops Q2 EPS by 8c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/10/2026

1. HUM
2. SPCX
3. ALHC
4. PEP
5. T
6. SPY
7. CVS
8. UNH
9. DAL
10. TMUS

Go back to CytRx (CYTR) Tops Q2 EPS by 8c

CytRx Corporation Reports Second Quarter 2018 Financial Results

August 6, 2018 8:30 AM EDT

LOS ANGELES, Aug. 6, 2018 /PRNewswire/ -- CytRx Corporation (Nasdaq: CYTR), a biopharmaceutical research and development company specializing in oncology, today announced financial results for the quarter ended June 30, 2018, and provided an overview of recent accomplishments and plans for its research and development programs.

"To date, 2018 has been marked by several important achievements, most notably the launch of Centurion BioPharma Corporation, which is focused on personalized medicine in advancing our... More